These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 25556809

  • 1. Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
    Lerner PP, Miodownik C, Lerner V.
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):321-34. PubMed ID: 25556809
    [Abstract] [Full Text] [Related]

  • 2. Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.
    Lerner V, Miodownik C.
    Curr Psychiatry Rep; 2011 Aug; 13(4):295-304. PubMed ID: 21519907
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of tardive syndromes].
    Horváth K, Aschermann Z, Komoly S, Kovács A, Kovács N.
    Psychiatr Hung; 2014 Aug; 29(2):214-24. PubMed ID: 25041749
    [Abstract] [Full Text] [Related]

  • 4. Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesia.
    Meyer JM.
    CNS Spectr; 2016 Dec; 21(S1):13-24. PubMed ID: 28044943
    [Abstract] [Full Text] [Related]

  • 5. Identification and management of tardive dyskinesia: A case series and literature review.
    Khouzam HR.
    Postgrad Med; 2015 Dec; 127(7):726-37. PubMed ID: 26216578
    [Abstract] [Full Text] [Related]

  • 6. Treatment Recommendations for Tardive Dyskinesia.
    Ricciardi L, Pringsheim T, Barnes TRE, Martino D, Gardner D, Remington G, Addington D, Morgante F, Poole N, Carson A, Edwards M.
    Can J Psychiatry; 2019 Jun; 64(6):388-399. PubMed ID: 30791698
    [Abstract] [Full Text] [Related]

  • 7. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Niemann N, Jankovic J.
    Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607
    [Abstract] [Full Text] [Related]

  • 9. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG, Breden EL.
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [Abstract] [Full Text] [Related]

  • 10. Valbenazine for Tardive Dyskinesia.
    Freudenreich O, Remington G.
    Clin Schizophr Relat Psychoses; 2017 Apr; 11(2):113-119. PubMed ID: 28742396
    [Abstract] [Full Text] [Related]

  • 11. Nonparkinsonism movement disorders in the elderly.
    Chen JJ, Lee KC.
    Consult Pharm; 2006 Jan; 21(1):58-71. PubMed ID: 16524353
    [Abstract] [Full Text] [Related]

  • 12. Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia.
    Sharma VD, Gupta HV, Espay AJ.
    Tremor Other Hyperkinet Mov (N Y); 2020 Dec 16; 10():56. PubMed ID: 33362950
    [Abstract] [Full Text] [Related]

  • 13. How best to address these common movement disorders.
    Yaman A, Akdeniz M, Yaman H.
    J Fam Pract; 2011 Dec 16; 60(12):721-5. PubMed ID: 22163354
    [No Abstract] [Full Text] [Related]

  • 14. Drug therapies for tardive dyskinesia: part 2.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2011 Jul 16; 49(7):17-20. PubMed ID: 21667885
    [Abstract] [Full Text] [Related]

  • 15. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C, Jankovic J.
    Expert Rev Neurother; 2006 Jan 16; 6(1):7-17. PubMed ID: 16466307
    [Abstract] [Full Text] [Related]

  • 16. [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge].
    Sakata M, Ito H.
    Brain Nerve; 2022 May 16; 74(5):571-574. PubMed ID: 35589649
    [Abstract] [Full Text] [Related]

  • 17. Tardive Dyskinesia: Treatment Update.
    Arya D, Khan T, Margolius AJ, Fernandez HH.
    Curr Neurol Neurosci Rep; 2019 Aug 16; 19(9):69. PubMed ID: 31420757
    [Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.
    Ryu S, Yoo JH, Kim JH, Choi JS, Baek JH, Ha K, Kwon JS, Hong KS.
    J Clin Psychopharmacol; 2015 Feb 16; 35(1):13-21. PubMed ID: 25485636
    [Abstract] [Full Text] [Related]

  • 19. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
    Zivković SA, Costa G, Bond G, Abu-Elmagd KM.
    Acta Neurol Scand; 2008 May 16; 117(5):351-3. PubMed ID: 17995990
    [Abstract] [Full Text] [Related]

  • 20. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T.
    Expert Opin Investig Drugs; 2015 Jun 16; 24(6):737-42. PubMed ID: 25809133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.